Since our founding in 2009, Brickell Biotech has been at the forefront of developing innovative and differentiated therapeutics for the treatment of skin diseases.
Clinical trials are research studies designed to answer scientific questions and discover improved methods for treating or preventing diseases. Clinical trial data provides fundamental evidence for the U.S. Food and Drug Administration (FDA) and other regulatory agencies that a therapy will work effectively in a great number of patients. Conducting clinical trials is also crucial for establishing the safety, efficacy, and viability of investigational treatments, including our own in the therapeutic areas of hyperhidrosis, contact dermatitis, cutaneous T-cell Lymphoma, and psoriasis.
Our Clinical trials can’t happen without patient participation. In fact, patient participation is fundamental to the development of innovative therapeutics. Please visit clinicaltrials.gov to see a listing of clinical trials that may be accepting patients.